Condition
Infection of Total Hip Joint Prosthesis
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (2)
Trial Status
Completed3
Unknown2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04993027Phase 2Not Yet RecruitingPrimary
Topical Vancomycin for Infection Prophylaxis in TJA
NCT02842684Not ApplicableCompletedPrimary
Orthopedic Digital Planning for Total Hip Arthroplasties
NCT05369104Phase 2UnknownPrimary
Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR.
NCT01854138Not ApplicableCompletedPrimary
Evaluating Advantages of Prevena After Hip and Knee Arthroplasty
NCT01970228Not ApplicableCompleted
Imaging of Joint Replacement Complications by PET/CT
NCT01517737UnknownPrimary
Immunology of Failing Metal-on-Metal Hip Replacement
Showing all 6 trials